{
  "id": 11076400,
  "title": "Sensex today | Stock Market Live Updates: Kotak Mahindra Bank (₹417.60) – BUY",
  "url": "https://urgent.news/2026/10/01/sensex-today-stock-market-live-updates-kotak-mahindra-bank-417-60-buy",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-01T01:34:45.000Z",
  "source": {
    "name": "Hindu BusinessLine",
    "slug": "hindu-businessline",
    "url": "https://www.thehindubusinessline.com/markets/sensex-nifty50-today-stock-market-live-updates-1-october-2026/article71528461.ece"
  },
  "original_language": "en",
  "account": "On 1st October 2026, the Sensex rose, bringing the Nifty 50 index higher. Kotak Mahindra Bank's stock increased to ₹417.60, making it an attractive buy according to market analysts. The stock crossed the 100-Day Moving Average of ₹396, providing immediate support at ₹406. A crucial support zone lies between ₹400 and ₹396, below which the stock could face trouble. The intermediate resistance is at ₹440, and analysts anticipate the stock to potentially reach ₹460 in the forthcoming weeks. Trading at ₹418 now is advised, with accumulation possible on dips at ₹408. A stop-loss of ₹392 is suggested, which should be trailed up to ₹425 once the stock surpasses ₹433. As the price reaches ₹443, the stop-loss should be revised to ₹435, and subsequently to ₹445 when the stock hits ₹455. The stock should be exited at ₹460. Acrotech Biopharma, a subsidiary of Aurobindo Pharma, recently introduced Adquey in the U.S. for treating mild-to-moderate atopic dermatitis and set up a dedicated dermatology business unit. This move grants the company entry into the U.S. dermatology market, valued at approximately $1.3 billion. The guide offers intraday trading insights with Nifty50 supports, resistances, and precise entry/exit strategies for leading stocks and index futures.",
  "summary": "Sensex, Nifty, Share Prices Live: The short-term outlook is bullish for Kotak Mahindra Bank. The stock has risen well in the last couple of days.",
  "key_points": [
    "Kotak Mahindra Bank stock at ₹417.60, recommended as BUY",
    "Sensex and Nifty 50 index both rose on 1st October 2026",
    "Support zone identified between ₹400 and ₹396 for the stock"
  ],
  "editors_take": "Kotak Mahindra Bank's stock rise above its 100-Day Moving Average makes it attractive to analysts, who see potential for growth while suggesting strategic entry and exit points for investors.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}